Growth Metrics

Bioadaptives (BDPT) Amortization of Deferred Charges (2021 - 2024)

Bioadaptives' Amortization of Deferred Charges history spans 4 years, with the latest figure at $8387.0 for Q2 2024.

  • Quarterly results put Amortization of Deferred Charges at $8387.0 for Q2 2024, down 80.1% from a year ago — trailing twelve months through Dec 2024 was $52592.0 (down 56.01% YoY), and the annual figure for FY2025 was $25132.0, down 52.21%.
  • Amortization of Deferred Charges for Q2 2024 was $8387.0 at Bioadaptives, down from $44205.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $118450.0 in Q4 2021 to a low of $2680.0 in Q2 2021.
  • The 4-year median for Amortization of Deferred Charges is $43178.5 (2023), against an average of $44876.0.
  • The sharpest move saw Amortization of Deferred Charges skyrocketed 2217.35% in 2022, then plummeted 87.84% in 2023.
  • Year by year, Amortization of Deferred Charges stood at $118450.0 in 2021, then crashed by 34.18% to $77965.0 in 2022, then plummeted by 65.07% to $27237.0 in 2023, then crashed by 69.21% to $8387.0 in 2024.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $8387.0, $44205.0, and $27237.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.